Obermatt
See Similar Stocks →

Tilray Brands

NSQ:TLRY · US88688T2096
PharmaceuticalsMedium

360

18
Profit price58
Owner Earnings Yield1
Dividend Yield1
Price/Sales96
EV / Gross Profit47
Price/Book73
Return on Capital33
Cash Return on Capital6
Return on Equity4
EBIT Margin22
Gross Profitability23
Accruals100
Owner Earnings Margin16
Sales growth49
Profit growth88
Reinvestment21
Price momentum41
Debt load38
Refinancing100
Debt Payback1
Liquidity79
Analyst ratings3
Opinion Changes50
Price Target Upside63
Market mood6
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Tilray Brands doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryCanada
IndustryPharmaceuticals
SizeMedium
TypePublic Company
ExchangeNASDAQGS
Employees592
Websitetilray.com
ISINUS88688T2096
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
NutraceuticalLifestyleDistilleryCannabisAlternative MedicineWellness and RecoveryCustomer ServiceMedicalPharmaceutical

Description

Tilray Brands, Inc. (Tilray) operates as a leading global lifestyle consumer products company with operations in Canada, the United States, Europe, Australia, and Latin America. The company's portfolio includes some of the most well-known and belove…

Analysis

Middle-of-the-road

Tilray Brands, Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is solid; the safety picture is stretched. The company scores 4/20 on our value-creation score: not creating value. Analyst sentiment is cautious.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
59
2026

All-time high

63

Mar 2026

All-time low

59

Jun 2026

Average rank

61

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
96
—
—
—
Price/Earnings
10
—
—
—
Price/Book
73
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
67
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Tilray Brands with its peers
MediciNova
NMQ:MNOV
21
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Zymeworks
NSQ:ZYME
43
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Coeptis Therapeutics
NAQ:COEP
27
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Cigna
NYQ:CI
59
CountryUSA
IndustryHealth Care Providers & Services
SizeXX-Large
Full Stock Analysis →
Quest Diagnostics
NYQ:DGX
35
CountryUSA
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Dominari Holdings
NAQ:DOMH
—
CountryUSA
IndustryCapital Markets
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →